Tuesday, November 28, 2017 11:04:21 AM
Product Co., with a mass mktg base to health
Professionals.
With El Camino Hospital trial not enrolling anymore, Cyrcadia last public statement of 83% or better efficacy,
and Ohio State CCC still enrolling people for the study (The fact that the Ohio State trial is still open is great and could possibly mean they are seeing good results), I'd say FDA approval is getting closer and closer, maybe less than a year out. 2 million shares held her for nine years what's one more.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM